Grants per year
Fingerprint
Dive into the research topics where Cancer Center is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Joann Sweasy
- University of Arizona, Cancer Center
- University of Arizona, Cellular and Molecular Medicine
- University of Arizona, Chemistry and Biochemistry
- University of Arizona, Radiation Oncology
- University of Arizona, Cancer Biology - GIDP
- University of Arizona, Genetics - GIDP
- University of Arizona, Chemistry and Biochemistry
Person: Academic
-
Medical University of South Carolina - Cancer Center Support Grant
Kraft, A. (PI), Zhou, D. (PI), Obeid, L. (PI), Bielawska, A. (PI), Harrison, A. L. (PI), Garrett-Mayer, E. (PI), Lemasters, J. (PI), Hall, P. (PI), Stuart, R. (PI) & Alberg, A. (PI)
4/1/09 → …
Project: Research project
-
-
THE ROLE OF PROTEIN KINASE C IN MEDIATING N-RAS PROTEIN
Kraft, A. (PI)
6/5/90 → …
Project: Research project
-
Functional roles and cancer variants of the bifunctional glycosylase NEIL2
Hua, A. B. & Sweasy, J. B., 2023, (Accepted/In press) In: Environmental and Molecular Mutagenesis.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
A Human MSH6 Germline Variant Associated With Systemic Lupus Erythematosus Induces Lupus-like Disease in Mice
Meas, R., Nititham, J., Taylor, K. E., Maher, S., Clairmont, K., Carufe, K. E. W., Kashgarian, M., Nottoli, T., Cheong, A., Nagel, Z. D., Gaffney, P. M., Criswell, L. A. & Sweasy, J. B., Sep 2022, In: ACR Open Rheumatology. 4, 9, p. 760-770 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer
Symonds, L., Jenkins, I., Linden, H. M., Kurland, B., Gralow, J. R., Gadi, V., Ellis, G. K., Wu, Q., Rodler, E., Chalasani, P., Chai, X., Riedel, J., SCCA Network Investigators, N. I., Stopeck, A., Brown-Glaberman, U. & Specht, J. M., Jan 2022, In: Clinical Breast Cancer. 22, 1, p. 32-42 11 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations
Datasets
-
A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9–11 year-old girls and boys – clinical protocol
Zeng, Y. (Creator), Moscicki, A.-B. (Contributor), Sahasrabuddhe, V. V. (Contributor), Garcia, F. (Creator), Woo, H. (Creator), Hsu, C.-H. (Contributor), Szabo, E. (Creator), DImond, E. (Contributor), Vanzzini, S. (Creator), Mondragon, A. (Creator), Butler, V. (Creator), DeRose, H. (Creator) & Chow, H.-H. S. (Contributor), figshare, 2019
DOI: 10.6084/m9.figshare.c.4455557.v1, https://springernature.figshare.com/collections/A_prospective_single-arm_open-label_non-randomized_phase_IIa_trial_of_a_nonavalent_prophylactic_HPV_vaccine_to_assess_immunogenicity_of_a_prime_and_deferred-booster_dosing_schedule_among_9_11_year-old_girls_and_boys_clinical_protocol/4455557/1
Dataset
-
Additional file 2: of Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial
Goodman, P. J. (Creator), Tangen, C. M. (Creator), Darke, A. K. (Creator), Arnold, K. B. (Creator), Hartline, J. (Creator), Yee, M. (Creator), Anderson, K. (Creator), Caban-Holt, A. (Creator), Christen, W. G. (Creator), Cassano, P. A. (Creator), Lance, P. (Creator), Klein, E. A. (Creator), Crowley, J. J. (Creator), Minasian, L. M. (Creator) & Meyskens, F. L. (Creator), figshare, 2016
DOI: 10.6084/m9.figshare.c.3631349_d2.v1, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Opportunities_and_challenges_in_incorporating_ancillary_studies_into_a_cancer_prevention_randomized_clinical_trial/4424951/1
Dataset
-
Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial
Goodman, P. J. (Creator), Tangen, C. M. (Creator), Darke, A. K. (Creator), Arnold, K. B. (Creator), Hartline, J. (Creator), Yee, M. (Creator), Anderson, K. (Creator), Caban-Holt, A. (Creator), Christen, W. G. (Creator), Cassano, P. A. (Creator), Lance, P. (Creator), Klein, E. A. (Creator), Crowley, J. J. (Creator), Minasian, L. M. (Creator) & Meyskens, F. L. (Creator), figshare, 2016
DOI: 10.6084/m9.figshare.c.3631349.v1, https://figshare.com/collections/Opportunities_and_challenges_in_incorporating_ancillary_studies_into_a_cancer_prevention_randomized_clinical_trial/3631349/1
Dataset